Economic Impact of Dengue: A Review
Author Information
Author(s): Mark E. Beatty, Philippe Beutels, Martin I. Meltzer, Donald S. Shepard, Joachim Hombach, Raymond Hutubessy, Damien Dessis, Laurent Coudeville, Benoit Dervaux, Ole Wichmann, Harold S. Margolis, Joel N. Kuritsky
Primary Institution: Pediatric Dengue Vaccine Initiative, International Vaccine Institute
Hypothesis
What is the economic burden of dengue and how can it inform vaccine development?
Conclusion
The economic literature on dengue is limited and often inconsistent, highlighting the urgent need for more targeted health economic research.
Supporting Evidence
- Dengue causes an estimated 50 million infections and 20,000 deaths annually.
- The economic literature on dengue is sparse and often conflicting.
- Health economic research specific to dengue is urgently needed.
Takeaway
Dengue is a serious disease that costs a lot of money to treat, and we need better studies to understand how to prevent it, especially with vaccines.
Methodology
A systematic review of health economics studies related to dengue was conducted, involving searches of multiple databases and expert panel assessments.
Potential Biases
Potential bias due to reliance on published literature and expert opinions.
Limitations
The review primarily captured published studies, which may introduce publication bias.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website